The 3 analysts offering 12-month price forecasts for Lexicon Pharmaceuticals Inc have a median target of 10.00, with a high estimate of 16.00 and a low estimate of 2.60. The median estimate represents a +215.46% increase from the last price of 3.17.
The current consensus among 3 polled investment analysts is to Buy stock in Lexicon Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.14
Reporting Date Nov 03
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.